Bank of New York Mellon Corp - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 141 filers reported holding GENMAB A/S in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$3,032,753
-18.8%
85,987
-12.5%
0.00%0.0%
Q2 2023$3,734,358
-6.6%
98,247
-7.2%
0.00%0.0%
Q1 2023$3,996,518
-14.1%
105,840
-3.6%
0.00%0.0%
Q4 2022$4,653,355
+14.0%
109,801
-13.6%
0.00%0.0%
Q3 2022$4,083,000
-7.4%
127,045
-6.3%
0.00%0.0%
Q2 2022$4,407,000
+4.3%
135,633
+16.1%
0.00%0.0%
Q1 2022$4,227,000
-4.8%
116,847
+4.2%
0.00%0.0%
Q4 2021$4,439,000
-8.2%
112,182
+1.3%
0.00%0.0%
Q3 2021$4,838,000
+56.9%
110,698
+46.6%
0.00%0.0%
Q2 2021$3,083,000
+23.4%
75,503
-0.8%
0.00%0.0%
Q1 2021$2,499,000
-21.5%
76,122
-2.8%
0.00%0.0%
Q4 2020$3,185,000
+11.2%
78,335
+0.1%
0.00%0.0%
Q3 2020$2,865,000
-6.9%
78,233
-13.8%
0.00%0.0%
Q2 2020$3,076,000
+71.5%
90,735
+7.2%
0.00%0.0%
Q1 2020$1,794,000
-11.1%
84,656
-6.3%
0.00%0.0%
Q4 2019$2,018,000
+9.2%
90,353
-1.0%
0.00%0.0%
Q3 2019$1,848,00091,2290.00%
Other shareholders
GENMAB A/S shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders